The Role of α1- and α2-Adrenoreceptors on Venlafaxineinduced Elevation of Extracellular Serotonin, Noradrenaline and Dopamine Levels in the Rat Prefrontal Cortex and Hippocampus
The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
The role of adrenergic α 1 - and α 2 -adrenoreceptors in augmentation of venlafaxine-induced elevation of extracellular serotonin (5-HT),noradrenaline (NA) and dopamine (DA) levels in the rat prefrontal cortex (PFC) and hippocampus (HIPP) was studied by in vivo microdialysis in anaesthetized rats. The α 1 -adrenoreceptor antagonist prazosin given alone (0.3 mg/kg, s.c.) induced only a moderate reduction of hippocampal 5-HT and NA levels. The α 2 -adrenoreceptor antagonistidazoxan (1.5 mg/kg, s.c.) causes moderate increases in the levels of 5-HT and DA in the PFC. The mixed 5-HT and NA reuptake inhibitor venlafaxine (10 mg/kg, i.p.) increased the efflux of 5-HT, NA and DA almost equally, to approximately 200% of the control levels in the PFC. The levels of 5-HT increased to 310%, an effect approximately twice the effect on NA in the HIPP. Venlafaxine also produced a moderate increase in DA levels in the PFC but had no effect in the HIPP. Pre-treatment with prazosin caused a significant attenuation of the venlafaxine induced 5-HT effect in the PFC, and a moderate increase in DA levels in the HIPP. Prazosin had no significant effect on the venlafaxine-induced increase of the NA levels in PFC or HIPP. A combined treatment of venlafaxine with idazoxan increased the venlafaxine NA and DA effects in PFC by a factor of two and resulted in a very robust five-foldaugmentation of NA and DA concentrations in the HIPP. In summary, idazoxan was found to produce a potent enhancement of the venlafaxine effect to increase extracellular NA and DA levels in the PFC and, inparticular, in the HIPP. Idazoxan had no effect on venlafaxine-induced elevation of extracellular 5-HT levels in either PFC or HIPP and prazosin induced a decrease of 5-HT in the PFC. The present data suggest that blockade of α 2 -adrenoreceptors may play an important role inaugmentation of the effects of mixed monoamine reuptake inhibitors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Z-drugs' withdrawal symptoms are similar to those observed with BDZ (see Table 1; 31).”
From Coming Off Prescribed Psychotropic Medications: Insights from Their Use as Recreational Drugs (2020) · cites this paper as [31]
In the citing paper
“In the prefrontal cortex nerve terminals there are only few DA, but plenty of both NE and 5-HT, transporters (Weikop et al., 2004).”
From Is There a Potential of Misuse for Venlafaxine and Bupropion? (2018) · cites this paper as Weikop et al., 2004
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
Mayberg, H. S., Liotti, M., Brannan, S. K., McGinnis, S., Mahurin, R. K., Jerabek, P. A., Silva, J. A., Tekell, J. L., Martin, C. C., Lancaster, J. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.675 · Cited by 2,416
Limbic-cortical dysregulation: a proposed model of depression
(1997) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.9.3.471 · Cited by 1,585
Neuroimaging studies of mood disorders
Drevets, W. C. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01020-9 · Cited by 1,313 · cited 1×
“These brain areas, together with amygdala, are implicated in the aetiology of mood disorders, as revealed by neuroimaging studies in depressed patients (Mayberg, 1997; Mayberg et al., 1999; Drevets, 2000, 2001).”
BackgroundDrevets, W. C. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00203-8 · Cited by 1,146 · cited 1×
“These brain areas, together with amygdala, are implicated in the aetiology of mood disorders, as revealed by neuroimaging studies in depressed patients (Mayberg, 1997; Mayberg et al., 1999; Drevets, 2000, 2001).”
BackgroundSvensson, T. H., Bunney, B. S., & Aghajanian, G. K. (1975) · Brain Research · doi:10.1016/0006-8993(75)90276-0 · Cited by 1,009
Artigas, F., Romero, L., de Montigny, C., & Blier, P. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10037-0 · Cited by 655 · cited 1×
“Another proposed approach is based on a combined therapy with SSRIs, SNRIs or monoamine oxidase inhibitors given together with 5-HT1A receptor antagonists such as pindolol (Artigas et al., 1994, 1996; Blier et al., 1987).”
MethodSmith, D., Dempster, C., Glanville, J., Freemantle, N., & Anderson, I. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.5.396 · Cited by 538 · cited 2×
“Email: piw@neurosearch.dk selective serotonin reuptake inhibitors (SSRIs) (Guelfi, 1995; Montgomery, 1995; Benkert et al., 1996) and some other antidepressants (Smith et al., 2002).”
BackgroundArtigas, F. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030084009 · Cited by 510 · cited 1×
“Another proposed approach is based on a combined therapy with SSRIs, SNRIs or monoamine oxidase inhibitors given together with 5-HT1A receptor antagonists such as pindolol (Artigas et al., 1994, 1996; Blier et al., 1987).”
Method
Research works printed but not linked: 10
- Bel N, 1996, J Pharmacol Exp Ther, 278, 1064
- Dawson L A, 1999, Neuro-pharmacology, 38, 1153
- de Boer T H, 1996, J Pharmacol Exp Ther, 277, 852
- Dennis T, 1987, J Pharmacol Exp Ther, 241, 642
- Gobert A, 1995, J Pharmacol Exp Ther, 273, 1032
- Guelfi J D, 1995, J Clin Psychiatry, 56, 450
- Hjorth S, 1995, Neuro-pharmacology, 34, 615
- Millan M J, 2000, J Pharmacol Exp Ther, 295, 1206
- Millan M J, 2001, J Pharmacol Exp Ther, 298, 565
- Xu K, 1993, J Pharmacol Exp Ther, 267, 211
Cited by
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Stahl, S. M., Grady, M. M., Moret, C., & Briley, M. (2005) · CNS Spectrums · doi:10.1017/s1092852900019726 · Cited by 458
Novel psychoactive substances of interest for psychiatry
Schifano, F., Orsolini, L., Duccio Papanti, G., & Corkery, J. M. (2015) · World Psychiatry · doi:10.1002/wps.20174 · Cited by 321
Auclair, A. L., Martel, J. C., Assié, M. B., Bardin, L., Heusler, P., Cussac, D., Marien, M., Newman-Tancredi, A., O'Connor, J. A., & Depoortère, R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.02.024 · Cited by 263
A Review of Serotonin Toxicity Data: Implications for the Mechanisms of Antidepressant Drug Action
Gillman, P. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.016 · Cited by 248
Metadata
- Authors
- Weikop, P., Kehr, J., & Scheel-Krüger, J.
- Affiliations
- NeuroSearch (Denmark) (DK)
- Karolinska Institutet (SE)
- Department of Pharmacology NeuroSearch A/S, Ballerup, Denmark
- Corresponding author
- Weikop, P.
- ORCID
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2004-09
- Volume
- 18
- Issue
- 3
- Pages
- 395-403
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W1989558146
- Cited by
- 57
- References
- 71
- Citations by year
- 2024: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 1 · 2015: 4 · 2014: 1 · 2013: 3 · 2012: 4
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- venlafaxine, alpha1-adrenoceptors, alpha2-adrenoceptors, prazosin, idazoxan, serotonin, norepinephrine, dopamine, extracellular neurotransmitter levels, prefrontal cortex, hippocampus, monoamine reuptake inhibition, drug augmentation, sympathomimetic drugs
- MeSH terms
- Venlafaxine Hydrochloride, Adrenergic alpha-Antagonists, Animals, Cyclohexanols, Dopamine, Drug Interactions, Hippocampus, Male, Norepinephrine, Prazosin, Serotonin, Time Factors, Biogenic Monoamines, Rats, Wistar, Selective Serotonin Reuptake Inhibitors, Prefrontal Cortex, Receptors, Adrenergic, alpha-1, Receptors, Adrenergic, alpha-2, Idazoxan, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Role of α1- and α2-Adrenoreceptors on Venlafaxineinduced Elevation of Extracellular Serotonin, Noradrenaline and Dopamine Levels in the Rat Prefrontal Cortex and Hippocampus. https://app.cochat.ai/papers/10.1177/026988110401800311
- The paper
- Weikop, P., Kehr, J., & Scheel-Krüger, J. (2004). The Role of α1- and α2-Adrenoreceptors on Venlafaxineinduced Elevation of Extracellular Serotonin, Noradrenaline and Dopamine Levels in the Rat Prefrontal Cortex and Hippocampus. Journal of Psychopharmacology. https://doi.org/10.1177/026988110401800311
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.